{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:46:10Z","timestamp":1793313970860,"version":"4.5.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01283-2","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:11:22Z","timestamp":1789755082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial Intelligence in Pharmaceutical Regulatory Science: Opportunities, Challenges, and Emerging Frameworks"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2393-7643","authenticated-orcid":false,"given":"In\u00eas","family":"Lucas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9718-8035","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-548X","authenticated-orcid":false,"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"1283_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41120-025-00113-7","volume":"11","author":"K Ahluwalia","year":"2025","unstructured":"Ahluwalia K, Abernathy M, Beierle J, Cauchon N, Cronin D, Gaiki S, et al. The future of regulatory filings: digitalization. AAPS Open [Internet]. 2025;11:9. https:\/\/doi.org\/10.1186\/s41120-025-00113-7.","journal-title":"AAPS Open [Internet]"},{"issue":"5","key":"1283_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40264-022-01176-1","volume":"45","author":"B Kompa","year":"2022","unstructured":"Kompa B, Hakim JB, Palepu A, Kompa KG, Smith M, Bain PA, Woloszynek S, Painter JL, Bate A, Beam AL. Artificial intelligence based on machine learning in pharmacovigilance: a scoping review. Drug Saf. 2022;45(5):477\u201391. https:\/\/doi.org\/10.1007\/s40264-022-01176-1.","journal-title":"Drug Saf"},{"key":"1283_CR3","doi-asserted-by":"publisher","unstructured":"Lenarczyk G, Minssen T, Price N, Rai A. The future of AI regulation in drug development: A comparative analysis. J Law Biosci. 2025;12(2). https:\/\/doi.org\/10.1093\/jlb\/lsaf028.","DOI":"10.1093\/jlb\/lsaf028"},{"issue":"1","key":"1283_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2024.11.006","volume":"15","author":"L Fu","year":"2025","unstructured":"Fu L, Jia G, Liu Z, Pang X, Cui Y. The applications and advances of artificial intelligence in drug regulation: a global perspective. Acta Pharm Sin B. 2025;15(1):1\u201314. https:\/\/doi.org\/10.1016\/j.apsb.2024.11.006.","journal-title":"Acta Pharm Sin B"},{"key":"1283_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2025.100268","volume":"13","author":"S Pasas-Farmer","year":"2025","unstructured":"Pasas-Farmer S, Jain R. From discovery to delivery: governance of AI in the pharmaceutical industry. Green Anal Chem. 2025;13:100268. https:\/\/doi.org\/10.1016\/j.greeac.2025.100268.","journal-title":"Green Anal Chem"},{"key":"1283_CR6","doi-asserted-by":"publisher","first-page":"1437167","DOI":"10.3389\/fphar.2024.1437167","volume":"15","author":"W Oualikene-Gonin","year":"2024","unstructured":"Oualikene-Gonin W, Jaulent MC, Thierry JP, Oliveira-Martins S, Belgod\u00e8re L, Maison P, Ankri J. Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities. Front Pharmacol. 2024;15:1437167. https:\/\/doi.org\/10.3389\/fphar.2024.1437167.","journal-title":"Front Pharmacol"},{"key":"1283_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1208\/s12248-024-01006-5","volume":"27","author":"CS Ajmal","year":"2024","unstructured":"Ajmal CS, Yerram S, Abishek V, Muhammed Nizam VP, Aglave G, Devi Patnam J, Singh Raghuvanshi R, Srivastava S, Srivastava Saurabh S. Innovative approaches in regulatory affairs: Leveraging artificial intelligence and machine learning for efficient compliance and decision-making. AAPS J. 2024;27:22. https:\/\/doi.org\/10.1208\/s12248-024-01006-5.","journal-title":"AAPS J"},{"issue":"6","key":"1283_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/ph18060901","volume":"18","author":"SK Niazi","year":"2025","unstructured":"Niazi SK. Regulatory perspectives for AI\/ML implementation in pharmaceutical GMP environments. Pharmaceuticals. 2025;18(6):901. https:\/\/doi.org\/10.3390\/ph18060901.","journal-title":"Pharmaceuticals"},{"key":"1283_CR9","unstructured":"U.S. Food and Drug Administration. FDA expands AI capabilities and completes data platform consolidation. Retrieved May 18, 2026, from https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-expands-ai-capabilities-and-completes-data-platform-consolidation."},{"key":"1283_CR10","doi-asserted-by":"publisher","DOI":"10.2196\/101884","volume":"28","author":"TS Athni","year":"2026","unstructured":"Athni TS. US Food and Drug Administration shifts to AI-enhanced regulatory review with Elsa 4.0 and HALO. J Med Internet Res. 2026;28:e101884. https:\/\/doi.org\/10.2196\/101884.","journal-title":"J Med Internet Res"},{"issue":"15","key":"1283_CR11","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.3390\/ijms20153801","volume":"20","author":"S Nagai","year":"2019","unstructured":"Nagai S. Flexible and expedited regulatory review processes for innovative medicines and regenerative medical products in the US, the EU, and Japan. Int J Mol Sci. 2019;20(15):3801. https:\/\/doi.org\/10.3390\/ijms20153801.","journal-title":"Int J Mol Sci"},{"key":"1283_CR12","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA). PMDA AI Action Plan 2025. 2025. Retrieved May 13, 2026, from https:\/\/www.pmda.go.jp\/files\/000277511.pdf."},{"key":"1283_CR13","unstructured":"FDA\u2019s IT Strategy. Unlocking potential, leading transformation. Fda.Gov. 2023; Retrieved January 31, 2026, from https:\/\/www.fda.gov\/news-events\/fda-voices\/fdas-it-strategy-unlocking-potential-leading-transformation."},{"key":"1283_CR14","volume-title":"Reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle (EMA\/CHMP\/CVMP\/83833\/2023)","author":"European Medicines Agency","year":"2023","unstructured":"European Medicines Agency. Reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle (EMA\/CHMP\/CVMP\/83833\/2023). European Medicines Agency; 2023."},{"key":"1283_CR15","unstructured":"European Parliament. Proposal for a regulation on artificial intelligence (Artificial Intelligence Act). [Internet]. 2024. Retrieved 30 July, 2025, from: https:\/\/artificialintelligenceact.eu."},{"key":"1283_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/joch\/5202999","volume":"2026","author":"SK Niazi","year":"2026","unstructured":"Niazi SK. A critical review of the FDA\u2019s draft guidance on artificial intelligence in drug and biological product regulation. J Chem. 2026;2026:Article 5202999. https:\/\/doi.org\/10.1155\/joch\/5202999.","journal-title":"J Chem"},{"key":"1283_CR17","unstructured":"FDA. FDA announces completion of first AI-assisted scientific review pilot and aggressive agency-wide AI rollout timeline. 2025. Retrieved January 31, 2026, from https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-completion-first-ai-assisted-scientific-review-pilot-and-aggressive-agency-wide-ai."},{"key":"1283_CR18","unstructured":"European Medicines Agency. Data on medicines: ISO IDMP standards overview. Retrieved July 30, 2025, from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/data-medicines-iso-idmp-standards-overview."},{"key":"1283_CR19","unstructured":"European Medicines Agency. Substance, Product, Organisation and Referential (SPOR) master data. 2024. Retrieved July 21, 2025, from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/data-medicines-iso-idmp-standards-overview\/substance-product-organisation-referential-spor-master-data."},{"issue":"1","key":"1283_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41120-023-00077-6","volume":"9","author":"J Beierle","year":"2023","unstructured":"Beierle J, Algorri M, Cort\u00e9s M, Cauchon NS, Lennard A, Kirwan JP, Oghamian S, Abernathy MJ. Structured content and data management\u2014enhancing acceleration in drug development through efficiency in data exchange. AAPS Open. 2023;9(1):11. https:\/\/doi.org\/10.1186\/s41120-023-00077-6.","journal-title":"AAPS Open"},{"key":"1283_CR21","unstructured":"European Medicines Agency. AIMPA toolbox for AI in medicines regulation. 2026. Retrieved May 13, 2026, from https:\/\/www.ema.europa.eu\/en\/documents\/presentation\/presentation-aimpa-toolbox-ai-medicines-regulations-s-doyle_en.pdf."},{"key":"1283_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssci.2023.106314","volume":"168","author":"R Okamoto","year":"2023","unstructured":"Okamoto R, Kojima R, Nakatsui M. Toward AI-supported evaluation for safety control measures against near-miss events in pharmaceutical products. Saf Sci. 2023;168:106314. https:\/\/doi.org\/10.1016\/j.ssci.2023.106314.","journal-title":"Saf Sci"},{"issue":"5","key":"1283_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/S40290-022-00441-Z","volume":"36","author":"M Salas","year":"2022","unstructured":"Salas M, Petracek J, Yalamanchili P, Aimer O, Kasthuril D, Dhingra S, Junaid T, Bostic T. The use of artificial intelligence in pharmacovigilance: a systematic review of the literature. Pharm Med. 2022;36(5):295\u2013306. https:\/\/doi.org\/10.1007\/S40290-022-00441-Z.","journal-title":"Pharm Med"},{"key":"1283_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40264-025-01520-1","volume":"48","author":"L Wu","year":"2025","unstructured":"Wu L, Fang H, Qu Y, Xu J, Tong W. Leveraging FDA labeling documents and large language model to enhance annotation, profiling, and classification of drug adverse events with AskFDALabel. Drug Saf. 2025;48:655\u201365. https:\/\/doi.org\/10.1007\/s40264-025-01520-1.","journal-title":"Drug Saf"},{"key":"1283_CR25","doi-asserted-by":"publisher","unstructured":"Wakai T, Watanabe S, Ando T, Kajiyama K, Fukuda K, Iwasa E, Iwasaki Y, Iwagami M, Tanaka T, Maeda D, Uyama Y. Present and future post-marketing drug safety assessment in Japan: A PMDA perspective. Ther Innov Regul Sci. 2026; https:\/\/doi.org\/10.1007\/s43441-026-00964-6.","DOI":"10.1007\/s43441-026-00964-6"},{"issue":"8","key":"1283_CR26","doi-asserted-by":"publisher","first-page":"10.12968\/hmed.2","DOI":"10.12968\/hmed.2024.0972","volume":"86","author":"N Ardic","year":"2025","unstructured":"Ardic N, Dinc R. Artificial intelligence in healthcare: Current regulatory landscape and future directions. Br J Hosp Med. 2025;86(8):10.12968\/hmed.2024.0972.","journal-title":"Br J Hosp Med"},{"key":"1283_CR27","unstructured":"National Medical Products Administration (NMPA). Implementation opinions on \u201cArtificial Intelligence + Drug Regulation\u201d. 2026. Retrieved May 13, 2026, from https:\/\/www.ccfdie.org\/en\/fgflf\/webinfo\/2026\/04\/1778084898991081.htm."},{"issue":"1","key":"1283_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-025-01596-0","volume":"8","author":"T Hartung","year":"2025","unstructured":"Hartung T, Whelan M, Tong W, Califf RM. Is regulatory science ready for artificial intelligence? NPJ Digit Med. 2025;8(1):1\u20135. https:\/\/doi.org\/10.1038\/s41746-025-01596-0.","journal-title":"NPJ Digit Med"},{"key":"1283_CR29","doi-asserted-by":"publisher","unstructured":"Podichetty JT, Bauer AM, Xu R, Henscheid N, Anderson W, Khan A, Ma SC, Huynh H, Romero K. How AI transforms regulatory submission: current clinical implementation and future prospects. Clin Transl Sci. 2025;18(12):e70434. https:\/\/doi.org\/10.1111\/cts.70434.","DOI":"10.1111\/cts.70434"},{"key":"1283_CR30","unstructured":"U.S. Food and Drug Administration. Artificial intelligence and machine learning (AI\/ML) -enabled medical devices. 2025. Retrieved May 18, 2026, from https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/artificial-intelligence-software-medical-device."},{"key":"1283_CR31","doi-asserted-by":"publisher","unstructured":"Singh R, Zhou K, Auclair JR. Reimagining drug regulation in the age of AI: A framework for the AI-enabled ecosystem for therapeutics. Front Med. 2025;12 https:\/\/doi.org\/10.3389\/fmed.2025.1679611.","DOI":"10.3389\/fmed.2025.1679611"},{"key":"1283_CR32","unstructured":"European Medicines Agency. EMA and FDA set common principles for AI in medicine development. Retrieved May 18, 2026, from https:\/\/www.ema.europa.eu\/en\/news\/ema-fda-set-common-principles-ai-medicine-development-0."},{"key":"1283_CR33","doi-asserted-by":"publisher","unstructured":"Menengola E, Gabardo E, Gonz\u00e1lez Sanmiguel NN. The proposal of the European regulation on artificial intelligence. Sequ\u00eancia. 2022;43(91) https:\/\/doi.org\/10.5007\/2177-7055.2022.e91435.","DOI":"10.5007\/2177-7055.2022.e91435"},{"key":"1283_CR34","unstructured":"European Medicines Agency. Draft reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle. 2023. Retrieved May 18, 2026, https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf."},{"key":"1283_CR35","volume-title":"Artificial intelligence workplan to guide use of AI in medicines regulation","author":"European Medicines Agency","year":"2023","unstructured":"European Medicines Agency. Artificial intelligence workplan to guide use of AI in medicines regulation. 2023. Retrieved May 18, 2026, from https:\/\/www.ema.europa.eu\/en\/news\/artificial-intelligence-workplan-guide-use-ai-medicines-regulation."},{"key":"1283_CR36","unstructured":"Future of Life Institute. The act texts: EU Artificial Intelligence Act. 2024. Retrieved May 18, 2026, from https:\/\/artificialintelligenceact.eu\/the-act\/."},{"key":"1283_CR37","unstructured":"Pharmaceuticals and Medical Devices Agency. Report on AI-based software as a medical device (SaMD). 2023. Retrieved May 19, 2026, from https:\/\/www.pmda.go.jp\/files\/000266100.pdf."},{"key":"1283_CR38","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Anvisa adota estrat\u00e9gia baseada em intelig\u00eancia artificial para otimizar an\u00e1lise de medicamentos. 2024. Retrieved May 19, 2026, from https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/noticias-anvisa\/2024\/anvisa-adota-estrategia-baseada-em-inteligencia-artificial-para-otimizar-analise-de-medicamentos."},{"key":"1283_CR39","unstructured":"Innovation, Science and Economic Development Canada. Retrieved May 19, 2026, from Canada\u2019s artificial intelligence strategy. 2025. https:\/\/ised-isde.canada.ca\/site\/ai-strategy\/en."},{"key":"1283_CR40","unstructured":"Health Canada. Pan-Canadian guiding principles for artificial intelligence in health care. 2025. Retrieved May 13, 2026, from https:\/\/www.canada.ca\/en\/health-canada\/corporate\/transparency\/health-agreements\/pan-canadian-ai-guiding-principles.html."},{"key":"1283_CR41","unstructured":"Therapeutic Goods Administration. TGA report: Clarifying and strengthening the regulation of medical device software, including artificial intelligence (AI). 2024. Retrieved May 19, 2026, from https:\/\/consultations.tga.gov.au\/tga\/clarifying-and-strengthening-the-regulation-of-medical-device-software-including-artificial-intelligence-aipdf."},{"key":"1283_CR42","unstructured":"Australian Government Department of Health and Aged Care. Safe and responsible artificial intelligence in health care: Legislation and regulation review final report. 2025. Retrieved May 19, 2026, from https:\/\/www.health.gov.au\/resources\/publications\/safe-and-responsible-artificial-intelligence-in-health-care-legislation-and-regulation-review-final-report."},{"key":"1283_CR43","unstructured":"National Medical Products Administration. List of typical application scenarios of artificial intelligence in drug regulation [in Chinese]. 2024. Retrieved May 19, 2026, from https:\/\/www.nmpa.gov.cn\/xxgk\/fgwj\/gzwj\/gzwjzh\/20240618144318144.html."},{"key":"1283_CR44","unstructured":"Science and Technology Daily. China unveils AI+Drug Regulation implementation roadmap. 2026. Retrieved May 14, 2026, from https:\/\/www.stdaily.com\/web\/English\/2026-04\/20\/content_505120.html."},{"key":"1283_CR45","doi-asserted-by":"publisher","unstructured":"Liu Y, Yu W. Understanding AI risks from its characteristics and NMPA regulation perspectives. Insights Imaging. 2026;17(1):119 https:\/\/doi.org\/10.1186\/s13244-026-02283-8.","DOI":"10.1186\/s13244-026-02283-8"},{"key":"1283_CR46","unstructured":"L\u00e4kemedelsverket. L\u00e4kemedelsverket erbjuder generativ AI till l\u00e4kemedelsmyndigheter i EU. 2025. Retrieved May 13, 2026, from https:\/\/www.lakemedelsverket.se\/sv\/nyheter\/lakemedelsverket-erbjuder-generativ-ai-till-lakemedelsmyndigheter-i-eu."},{"key":"1283_CR47","doi-asserted-by":"publisher","first-page":"1233142","DOI":"10.3389\/fmed.2023.1233142","volume":"10","author":"R Khalil","year":"2023","unstructured":"Khalil R, Macdonald JC, Gustafson A, Aljuburi L, Bisordi F, Beakes-Read G. Walking the talk in digital transformation of regulatory review. Front Med. 2023;10:1233142. https:\/\/doi.org\/10.3389\/fmed.2023.1233142.","journal-title":"Front Med"},{"key":"1283_CR48","volume-title":"Guiding principles for good AI practice in drug development","author":"European Medicines Agency (EMA) & U.S. Food and Drug Administration (FDA)","year":"2026","unstructured":"European Medicines Agency (EMA) & U.S. Food and Drug Administration (FDA). Guiding principles for good AI practice in drug development. European Medicines Agency; 2026. Retrieved May 25, 2026, from https:\/\/www.ema.europa.eu\/en\/documents\/other\/guiding-principles-good-ai-practice-drug-development_en.pdf."},{"key":"1283_CR49","unstructured":"Therapeutic Goods Administration (TGA). Clarifying and strengthening the regulation of Medical Device Software including Artificial Intelligence (AI): Outcomes from the review of therapeutic goods legislation, regulation and guidance. 2025. Retrieved May 13, 2026, from https:\/\/www.tga.gov.au\/news\/news-articles\/tga-ai-review-outcomes-report-published."},{"key":"1283_CR50","doi-asserted-by":"publisher","unstructured":"de Araujo Dourado D, Aith FMA. A regula\u00e7\u00e3o da intelig\u00eancia artificial na sa\u00fade no Brasil come\u00e7a com a Lei Geral de Prote\u00e7\u00e3o de Dados Pessoais. Rev Saude Publica. 2022;56. https:\/\/doi.org\/10.11606\/S1518-8787.2022056004461.","DOI":"10.11606\/S1518-8787.2022056004461"},{"key":"1283_CR51","doi-asserted-by":"publisher","unstructured":"Romero-Obon M, Rouaz-El-Hajoui K, Sancho-Ochoa V, Vargas R, P\u00e9rez-Lozano P, Su\u00f1\u00e9-Pou M, Garc\u00eda-Montoya E. Human-in-the-loop AI use in ongoing process verification in the pharmaceutical industry. Information. 2025;16(12). https:\/\/doi.org\/10.3390\/info16121082.","DOI":"10.3390\/info16121082"},{"key":"1283_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jbi.2017.07.012","volume":"73","author":"K Kreimeyer","year":"2017","unstructured":"Kreimeyer K, Foster M, Pandey A, Arya N, Halford G, Jones SF, Forshee R, Walderhaug M, Botsis T. Natural language processing systems for capturing and standardizing unstructured clinical information: a systematic review. J Biomed Inform. 2017;73:14\u201329. https:\/\/doi.org\/10.1016\/j.jbi.2017.07.012.","journal-title":"J Biomed Inform"},{"key":"1283_CR53","unstructured":"IQVIA. NLP & Text Analytics for Regulatory Affairs [Internet]. Retrieved July 24, 2025, from https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/fact-sheets\/nlp-text-analytics-for-regulatory-affairs.pdf."},{"issue":"1","key":"1283_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ph18010047","volume":"18","author":"F Mirakhori","year":"2025","unstructured":"Mirakhori F, Niazi SK. Harnessing the AI\/ML in drug and biological products discovery and development: the regulatory perspective. Pharmaceuticals. 2025;18(1):Article 47. https:\/\/doi.org\/10.3390\/ph18010047.","journal-title":"Pharmaceuticals"},{"key":"1283_CR55","doi-asserted-by":"publisher","unstructured":"Pawar HB, Neelanshu N, Bhat GM, Srikanth A, Muragundi PM. Challenges of using artificial intelligence (natural language processing) tools for regulatory documentation. J Appl Pharm Sci. 2025; https:\/\/doi.org\/10.7324\/japs.2026.267918.","DOI":"10.7324\/japs.2026.267918"},{"issue":"2","key":"1283_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/widm.70010","volume":"15","author":"LC Budler","year":"2025","unstructured":"Budler LC, Chen H, Chen A, Topaz M, Tam W, Bian J, Stiglic G. A brief review on benchmarking for large language models evaluation in healthcare. Wiley Interdiscip Rev Data Min Knowl Discov. 2025;15(2):e70010. https:\/\/doi.org\/10.1002\/widm.70010.","journal-title":"Wiley Interdiscip Rev Data Min Knowl Discov"},{"key":"1283_CR57","doi-asserted-by":"publisher","first-page":"72894","DOI":"10.1109\/ACCESS.2021.3072900","volume":"9","author":"D Baviskar","year":"2021","unstructured":"Baviskar D, Ahirrao S, Potdar V, Kotecha K. Efficient automated processing of unstructured documents using artificial intelligence: a systematic literature review and future directions. IEEE Access. 2021;9:72894\u2013936. https:\/\/doi.org\/10.1109\/ACCESS.2021.3072900.","journal-title":"IEEE Access"},{"key":"1283_CR58","unstructured":"Li Y, Wehbe RM, Ahmad FS, Wang H, Luo Y. Clinical-Longformer and Clinical-BigBird: transformers for long clinical sequences. arXiv. 2022. https:\/\/arxiv.org\/abs\/2201.11838."},{"key":"1283_CR59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3389\/fcell.2020.00673","volume":"8","author":"N Perera","year":"2020","unstructured":"Perera N, Dehmer M, Emmert-Streib F. Named entity recognition and relation detection for biomedical information extraction. Front Cell Dev Biol. 2020;8:673. https:\/\/doi.org\/10.3389\/fcell.2020.00673.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1283_CR60","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4258\/HIR.2023.29.4.286","volume":"29","author":"MC Durango","year":"2023","unstructured":"Durango MC, Torres-Silva EA, Orozco-Duque A. Named entity recognition in electronic health records: a methodological review. Healthc Inform Res. 2023;29(4):286\u201399. https:\/\/doi.org\/10.4258\/HIR.2023.29.4.286.","journal-title":"Healthc Inform Res"},{"issue":"8","key":"1283_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2021.100312","volume":"2","author":"KW Siah","year":"2021","unstructured":"Siah KW, Kelley NW, Ballerstedt S, Holzhauer B, Lyu T, Mettler D, Sun S, Wandel S, Zhong Y, Zhou B, Pan S, Zhou Y, Lo AW. Predicting drug approvals: the Novartis data science and artificial intelligence challenge. Patterns. 2021;2(8):100312. https:\/\/doi.org\/10.1016\/j.patter.2021.100312.","journal-title":"Patterns"},{"key":"1283_CR62","doi-asserted-by":"publisher","unstructured":"Gawade VR, Apar KS, Mapari RD, Lahane HS, Pawar VR. From data to drugs: a review\u2014harnessing AI for accelerated pharmaceutical development. Int J Adv Res Sci Commun Technol. 2023;3(1). https:\/\/doi.org\/10.48175\/IJARSCT-12456.","DOI":"10.48175\/IJARSCT-12456"},{"issue":"12","key":"1283_CR63","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/17460441.2023.2153830","volume":"17","author":"F Ciray","year":"2022","unstructured":"Ciray F, Do\u011fan T. Machine learning-based prediction of drug approvals using molecular, physicochemical, clinical trial, and patent-related features. Expert Opin Drug Discov. 2022;17(12):1425\u201341. https:\/\/doi.org\/10.1080\/17460441.2023.2153830.","journal-title":"Expert Opin Drug Discov"},{"key":"1283_CR64","unstructured":"European Federation of Pharmaceutical Industries and Associations (EFPIA). Application of AI in a GMP\u00a0\/ Manufacturing environment \u2013 An industry approach (Version 1.0). EFPIA. 2024. Retrieved July 24, 2025, from https:\/\/www.efpia.eu\/media\/vqmfjjmv\/position-paper-application-of-ai-in-a-gmp-manufacturing-environment-sept2024.pdf."},{"issue":"7","key":"1283_CR65","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3390\/pharmaceutics15071916","volume":"15","author":"LK Vora","year":"2023","unstructured":"Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916. https:\/\/doi.org\/10.3390\/pharmaceutics15071916.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1283_CR66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.22159\/ijap.2026v18i2.57414","volume":"18","author":"JJ Narayanan","year":"2026","unstructured":"Narayanan JJ, Dhanabal SP, Nalin D, Karri VVSR. Integrating artificial intelligence in quality audits of oral solid dosage manufacturing facilities. Int J App Pharm. 2026;18(2):245\u201352. https:\/\/doi.org\/10.22159\/ijap.2026v18i2.57414.","journal-title":"Int J App Pharm"},{"key":"1283_CR67","unstructured":"Laxmi B, Kumar P, Kanna S, Pharm M. Deviation management and CAPA evolution in API manufacturing: toward a digitally transformed future. Int J Environ Sci. 2025;11(20). Retrieved from https:\/\/theaspd.com\/index.php."},{"key":"1283_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2025.101637","volume":"40","author":"N Lebe\u00f1a","year":"2025","unstructured":"Lebe\u00f1a N, Casillas A, P\u00e9rez A. Large language models aided patient progression documentation according to the ICD standard. Inform Med Unlocked. 2025;40:101637. https:\/\/doi.org\/10.1016\/j.imu.2025.101637.","journal-title":"Inform Med Unlocked"},{"key":"1283_CR69","unstructured":"IQVIA. Smart RIM 2.0: Accelerating Digital Transformation in Regulatory Submissions. 2022. Retrieved July 24, 2025, from https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/fact-sheets\/iqvia-rim-smart.pdf."},{"key":"1283_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2023.104285","volume":"138","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wang J, Ren P, ValizadehAslani T, Zhang Y, Hu M, Liang H. Fine-tuning BERT for automatic ADME semantic labeling in FDA drug labeling to enhance product-specific guidance assessment. J Biomed Inform. 2023;138:104285. https:\/\/doi.org\/10.1016\/j.jbi.2023.104285.","journal-title":"J Biomed Inform"},{"key":"1283_CR71","doi-asserted-by":"publisher","unstructured":"Hicks SA, Str\u00fcmke I, Thambawita V, Hammou M, Riegler MA, Halvorsen P, Parasa S. On evaluation metrics for medical applications of artificial intelligence. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-09954-8.","DOI":"10.1038\/s41598-022-09954-8"},{"key":"1283_CR72","doi-asserted-by":"publisher","first-page":"1598979","DOI":"10.3389\/fmed.2025.1598979","volume":"12","author":"H Kadi","year":"2025","unstructured":"Kadi H, Abdellatif A, Njamen DIK, Pereme F. Automatic extraction of SmPC document for IDMP data model construction using foundation LLM and RAG: A preliminary experiment for pharmaceutical regulatory affairs. Front Med. 2025;12:1598979. https:\/\/doi.org\/10.3389\/fmed.2025.1598979.","journal-title":"Front Med"},{"key":"1283_CR73","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1145\/3672608.3707749","volume-title":"Proceedings of the ACM Symposium on Applied Computing","author":"J Kim","year":"2025","unstructured":"Kim J, Hur M, Min M. From RAG to QA-RAG: Integrating generative AI for pharmaceutical regulatory compliance process. In: Proceedings of the ACM Symposium on Applied Computing. Association for Computing Machinery; 2025. pp. 1293\u20135. https:\/\/doi.org\/10.1145\/3672608.3707749."},{"key":"1283_CR74","doi-asserted-by":"publisher","unstructured":"Cotta R, Garvey M, McDermott O. The impact of integrating artificial intelligence into regulatory affairs functions in the Medtech industry. Expert Rev Med Devices. 2026. https:\/\/doi.org\/10.1080\/17434440.2026.2648001.","DOI":"10.1080\/17434440.2026.2648001"},{"issue":"3","key":"1283_CR75","first-page":"77","volume":"13","author":"K Nagar","year":"2025","unstructured":"Nagar K, Choudhary M, Yadav B, Rahi S, Upadhayay A. The future of regulatory submissions: Transition to eCTD 4.0. Int J Drug Regul Aff. 2025;13(3):77\u201384. https:\/\/www.ijdra.com\/index.php\/journal\/article\/view\/788.","journal-title":"Int J Drug Regul Aff"},{"issue":"2","key":"1283_CR76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.22270\/ijdra.v13i2.764","volume":"13","author":"A Muppalla","year":"2025","unstructured":"Muppalla A, Maddi BD, Maddi NV. Artificial intelligence in regulatory compliance: Transforming pharmaceutical and healthcare documentation. Int J Drug Regul Aff. 2025;13(2):73\u201380. https:\/\/doi.org\/10.22270\/ijdra.v13i2.764.","journal-title":"Int J Drug Regul Aff"},{"key":"1283_CR77","unstructured":"Lee SA, Wu A, Chiang JN. Clinical ModernBERT: an efficient and long context encoder for biomedical text. arXiv. 2025. http:\/\/arxiv.org\/abs\/2504.03964."},{"key":"1283_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/J.JBI.2023.104428","volume":"144","author":"S Kierner","year":"2023","unstructured":"Kierner S, Kucharski J, Kierner Z. Taxonomy of hybrid architectures involving rule-based reasoning and machine learning in clinical decision systems: A scoping review. J Biomed Inform. 2023;144:104428. https:\/\/doi.org\/10.1016\/J.JBI.2023.104428.","journal-title":"J Biomed Inform"},{"key":"1283_CR79","doi-asserted-by":"publisher","unstructured":"Morishige M, Koshihara R. Ensuring reproducibility in generative AI systems for general use cases: a framework for regression testing and open datasets. ArXiv. 2025. https:\/\/doi.org\/10.48550\/arXiv.2505.02854.","DOI":"10.48550\/arXiv.2505.02854"},{"key":"1283_CR80","doi-asserted-by":"publisher","unstructured":"Park H, Huynh K, Eiband M, Dillmann J, Mayer S, Sedlmair M. Evaluating generative AI in the lab: methodological challenges and guidelines. Int conference on intelligent user interfaces, proceedings IUI. 2026. pp. 599\u2013616. https:\/\/doi.org\/10.1145\/3742413.3789065.","DOI":"10.1145\/3742413.3789065"},{"key":"1283_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2026.115080","volume":"224","author":"S Page","year":"2026","unstructured":"Page S, Funke A, Juhnke M. AI\/ML in drug product development & manufacturing: Report on the 8th APV Winter conference. Eur J Pharm Biopharm. 2026;224:115080. https:\/\/doi.org\/10.1016\/j.ejpb.2026.115080.","journal-title":"Eur J Pharm Biopharm"},{"key":"1283_CR82","volume-title":"WHO Expert Committee on Specifications for Pharmaceutical Preparations: Forty-eighth report (WHO Technical Report Series No. 986)","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Annex 3: Good manufacturing practices: Guidelines on validation. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: Forty-eighth report (WHO Technical Report Series No. 986). World Health Organization; 2014."},{"key":"1283_CR83","volume-title":"Stakeholders\u2019 consultation on EudraLex Volume 4 \u2013 Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22","author":"European Commission, Directorate-General for Health and Food Safety","year":"2025","unstructured":"European Commission, Directorate-General for Health and Food Safety. Stakeholders\u2019 consultation on EudraLex Volume 4 \u2013 Good Manufacturing Practice Guidelines: Chapter 4, Annex 11 and New Annex 22. European Commission \u2013 Public Health; 2025. Retrieved January 15, 2026, from https:\/\/health.ec.europa.eu\/consultations\/stakeholders-consultation-eudralex-volume-4-good-manufacturing-practice-guidelines-chapter-4-annex_en."},{"key":"1283_CR84","volume-title":"Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle (EMA\/CHMP\/CVMP\/83833\/2023)","author":"European Medicines Agency, Committee for Medicinal Products for Human Use & Committee for Medicinal Products for Veterinary Use","year":"2024","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use & Committee for Medicinal Products for Veterinary Use. Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle (EMA\/CHMP\/CVMP\/83833\/2023). European Medicines Agency; 2024. Retrieved January 15, 2026, from https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf."},{"key":"1283_CR85","doi-asserted-by":"publisher","first-page":"1444763","DOI":"10.3389\/frobt.2024.1444763","volume":"11","author":"M Ennab","year":"2024","unstructured":"Ennab M, Mcheick H. Enhancing interpretability and accuracy of AI models in healthcare: A comprehensive review on challenges and future directions. Front Rob AI. 2024;11:1444763. https:\/\/doi.org\/10.3389\/frobt.2024.1444763.","journal-title":"Front Rob AI"},{"issue":"2","key":"1283_CR86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/bdcc5020020","volume":"5","author":"M Mora-Cantallops","year":"2021","unstructured":"Mora-Cantallops M, S\u00e1nchez-Alonso S, Garc\u00eda-Barriocanal E, Sicilia MA. Traceability for trustworthy AI: A review of models and tools. Big Data Cogn Comput. 2021;5(2):20. https:\/\/doi.org\/10.3390\/bdcc5020020.","journal-title":"Big Data Cogn Comput"},{"key":"1283_CR87","unstructured":"The Road to Explainable AI in GXP-Regulated Areas. Pharmaceutical Engineering\u00ae, 43(1), [Article]. International Society for Pharmaceutical Engineering. 2023. Retrieved 24 July, 2025, from https:\/\/ispe.org\/pharmaceutical-engineering\/january-february-2023\/road-explainable-ai-gxp-regulated-areas."},{"key":"1283_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.cogsys.2024.101243","volume":"86","author":"CO Retzlaff","year":"2024","unstructured":"Retzlaff CO, Angerschmid A, Saranti A, Schneeberger D, R\u00f6ttger R, M\u00fcller H, Holzinger A. Post-hoc vs ante-hoc explanations: xAI design guidelines for data scientists. Cogn Syst Res. 2024;86:101243. https:\/\/doi.org\/10.1016\/j.cogsys.2024.101243.","journal-title":"Cogn Syst Res"},{"key":"1283_CR89","doi-asserted-by":"publisher","unstructured":"Rosen KL, Mandl KD. Regulating flexibility for artificial intelligence: FDA experience with predetermined change control plans (Preprint). medRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.08.26.25334477.","DOI":"10.1101\/2025.08.26.25334477"},{"issue":"4","key":"1283_CR90","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/20954816.2025.2569584","volume":"13","author":"G Perboli","year":"2025","unstructured":"Perboli G, Simionato N, Pratali S. Navigating the AI regulatory landscape: balancing innovation, ethics, and global governance. Econ Polit Stud. 2025;13(4):367\u201397. https:\/\/doi.org\/10.1080\/20954816.2025.2569584.","journal-title":"Econ Polit Stud"},{"issue":"1","key":"1283_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13326-018-0179-8","volume":"9","author":"A N\u00e9v\u00e9ol","year":"2018","unstructured":"N\u00e9v\u00e9ol A, Dalianis H, Velupillai S, Savova G, Zweigenbaum P. Clinical natural language processing in languages other than English: opportunities and challenges. J Biomed Semant. 2018;9(1):12. https:\/\/doi.org\/10.1186\/s13326-018-0179-8.","journal-title":"J Biomed Semant"},{"key":"1283_CR92","unstructured":"ISPE. A proposal for a comprehensive quality overall summary: addressing inconsistencies in CTD Module\u00a02 structure. Pharmaceutical Engineering\u00ae, May\/June 2023 edition; 2023. Retrieved July 30, 2025 from https:\/\/www.ispe.org\/pharmaceutical-engineering\/may-june-2023\/proposal-comprehensive-quality-overall-summary."},{"key":"1283_CR93","unstructured":"FDA, & CDER. A regulatory perspective on the quality overall summary: Putting the pieces together. U.S. Food and Drug Administration. n.d. Retrieved July 30, 2025, from https:\/\/www.fda.gov\/files\/drugs\/published\/A-Regulatory-Perspective-on-the-Quality-Overall-Summary\u2014Putting-the-Pieces-Together.pdf."},{"issue":"12","key":"1283_CR94","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3390\/cancers14122897","volume":"14","author":"E Tasci","year":"2022","unstructured":"Tasci E, Zhuge Y, Camphausen K, Krauze AV. Bias and class imbalance in oncologic data\u2014towards inclusive and transferrable AI in large scale oncology data sets. Cancers. 2022;14(12):2897. https:\/\/doi.org\/10.3390\/cancers14122897.","journal-title":"Cancers"},{"issue":"1","key":"1283_CR95","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2478\/eustu-2024-0012","volume":"2024","author":"K Jones","year":"2024","unstructured":"Jones K. Adoption of identification of medicinal products standards in Europe: health authorities and industry insights. Econ Polit. 2024;2024(1):274\u201399. https:\/\/doi.org\/10.2478\/eustu-2024-0012.","journal-title":"Econ Polit"},{"key":"1283_CR96","unstructured":"UNICOM Project. Gap Analysis of Existing and Need for New Standards and Profiles (Deliverable D1.1). 2019. https:\/\/unicom-project.eu\/wp-content\/uploads\/2022\/01\/UNICOM_D-1.1-gap-analysis.v2_20210531.pdf."},{"issue":"7","key":"1283_CR97","doi-asserted-by":"publisher","DOI":"10.2196\/35724","volume":"10","author":"CN Vorisek","year":"2022","unstructured":"Vorisek CN, Lehne M, Klopfenstein SAI, Mayer PJ, Bartschke A, Haese T, Thun S. Fast healthcare interoperability resources (FHIR) for interoperability in health research: systematic review. JMIR Med Inform. 2022;10(7):e35724. https:\/\/doi.org\/10.2196\/35724.","journal-title":"JMIR Med Inform"},{"key":"1283_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2024.102043","volume":"32","author":"AM Abdelhaleem Ali","year":"2024","unstructured":"Abdelhaleem Ali AM, Alrobaian MM. Strengths and weaknesses of current and future prospects of artificial intelligence-mounted technologies applied in the development of pharmaceutical products and services. Saudi Pharm J. 2024;32:102043. https:\/\/doi.org\/10.1016\/j.jsps.2024.102043.","journal-title":"Saudi Pharm J"},{"key":"1283_CR99","unstructured":"Zhang, S., & Maharjan, S. Security, privacy, and agentic AI in a regulatory view: from definitions and distinctions to provisions and reflections. arXiv. 2026. http:\/\/arxiv.org\/abs\/2603.18914."},{"key":"1283_CR100","doi-asserted-by":"publisher","DOI":"10.2196\/79166","volume":"11","author":"MR Hasan","year":"2026","unstructured":"Hasan MR, Li J. Privacy-preserving collaborative diabetes prediction in heterogeneous health care systems: Algorithm development and validation of a secure federated ensemble framework. JMIR Diabetes. 2026;11:e79166. https:\/\/doi.org\/10.2196\/79166.","journal-title":"JMIR Diabetes"},{"key":"1283_CR101","unstructured":"European Medicines Agency. AI Observatory report 2025. 2025. Retrieved June 30, 2026, from: https:\/\/www.ema.europa.eu\/en\/documents\/report\/2025-ai-observatory-report_en.pdf."},{"key":"1283_CR102","unstructured":"U.S. Food and Drug Administration. FDA launches agency-wide AI tool \u201cElsa\u201d to optimize performance for the American people. 2025. Retrieved June 30, 2026, from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-launches-agency-wide-ai-tool-optimize-performance-american-people."},{"issue":"5","key":"1283_CR103","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s43441-025-00803-0","volume":"59","author":"MJ Lamberti","year":"2025","unstructured":"Lamberti MJ, Florez MI, Do H, Rosner S, Menard T, Nielson C, Donovan A, Ye J, Kaveripakam S, Schoeberl B, Hunt AR, Yeardley H. The adoption and use of artificial intelligence and machine learning in clinical development. Ther Innov Regul Sci. 2025;59(5):1074\u201386. https:\/\/doi.org\/10.1007\/s43441-025-00803-0.","journal-title":"Ther Innov Regul Sci"},{"issue":"1","key":"1283_CR104","first-page":"49","volume":"7","author":"RC Miller","year":"2026","unstructured":"Miller RC. Artificial intelligence driven regulatory affairs framework for accelerating global pharmaceutical product approvals through predictive compliance intelligence and automated submission management. Int J Eng Trends Technol Res. 2026;7(1):49\u201361.","journal-title":"Int J Eng Trends Technol Res"},{"key":"1283_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2026.1761641","volume":"8","author":"M Knott","year":"2026","unstructured":"Knott M, Krebs M, Kerscher A. Large language models in healthcare quality management: A European perspective on process automation and compliance. Front Digit Health. 2026;8:Article 1761641. https:\/\/doi.org\/10.3389\/fdgth.2026.1761641.","journal-title":"Front Digit Health"},{"key":"1283_CR106","volume-title":"From concept to compliance: Practical pathways for implementing artificial intelligence (AI) in regulated pharmaceutical environments","author":"International Society for Pharmaceutical Engineering","year":"2025","unstructured":"International Society for Pharmaceutical Engineering. From concept to compliance: Practical pathways for implementing artificial intelligence (AI) in regulated pharmaceutical environments. 2025. Retrieved June 30, 2026, from: https:\/\/ispe.org\/pharmaceutical-engineering\/ispeak\/concept-compliance-practical-pathways-implementing-artificial."},{"key":"1283_CR107","volume-title":"AI-enabled optimization of early-phase clinical trials pilot program: request for information","author":"U.S. Food and Drug Administration","year":"2026","unstructured":"U.S. Food and Drug Administration. AI-enabled optimization of early-phase clinical trials pilot program: request for information. Federal Register; 2026. Retrieved June 30, 2026, from: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2026-05-28\/pdf\/2026-10602.pdf."},{"key":"1283_CR108","volume-title":"Navigating the regulatory landscape: the ultimate guide to your IDMP journey.","author":"Ennov","year":"2023","unstructured":"Ennov. Navigating the regulatory landscape: the ultimate guide to your IDMP journey. 2023. Retrieved June 30, 2025, from: https:\/\/en.ennov.com\/wp-content\/uploads\/2023\/09\/eBook-Navigating-The-Regulatory-Landscape-The-Ultimate-Guide-to-Your-IDMP-Journey.pdf."},{"issue":"11","key":"1283_CR109","doi-asserted-by":"publisher","DOI":"10.4236\/pp.2023.1411030","volume":"14","author":"T Huma","year":"2023","unstructured":"Huma T, Peng Z. Introduction to regulatory affairs and different regulatory bodies for pharmaceutical products and impact of digitalization on regulatory affairs. Pharmacology & Pharmacy. 2023;14(11):Article 1030. https:\/\/doi.org\/10.4236\/pp.2023.1411030.","journal-title":"Pharmacology & Pharmacy"},{"key":"1283_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.websem.2024.100849","volume":"84","author":"L Waltersdorfer","year":"2025","unstructured":"Waltersdorfer L, Sabou M. Leveraging knowledge graphs for AI system auditing and transparency. J Web Semant. 2025;84:100849. https:\/\/doi.org\/10.1016\/j.websem.2024.100849.","journal-title":"J Web Semant"},{"issue":"4","key":"1283_CR111","doi-asserted-by":"publisher","first-page":"53","DOI":"10.22270\/IJDRA.V12I4.718","volume":"12","author":"LK Boopathi","year":"2024","unstructured":"Boopathi LK, Raja N. Artificial intelligence and machine learning: enhancing the future of regulatory affairs. Int J Drug Regul Aff. 2024;12(4):53\u201360. https:\/\/doi.org\/10.22270\/IJDRA.V12I4.718.","journal-title":"Int J Drug Regul Aff"},{"key":"1283_CR112","doi-asserted-by":"publisher","unstructured":"Somara S, Joshi AM, Mitra K, Desai S, Lundberg MS, Bhasin S, Hunsberger J. Artificial intelligence in biotechnology and pharmaceuticals: evolution, applications, and regulatory frontiers. Curr Stem Cell Rep. 2025;11(1). https:\/\/doi.org\/10.1007\/s40778-025-00249-y.","DOI":"10.1007\/s40778-025-00249-y"},{"key":"1283_CR113","doi-asserted-by":"publisher","unstructured":"Wasiullah M, Yadav P, Singh S. A review article on the Common Technical Document (CTD) regulatory dossier. Int J Pharm Res Appl. 2025;10:2777\u201382. https:\/\/doi.org\/10.35629\/4494-100227772782.","DOI":"10.35629\/4494-100227772782"},{"key":"1283_CR114","unstructured":"Gyzen, M. The future of RIM is cross-functional integration: ready your organization to support the next generation of RIM. 2021. Retrieved July 29, 2025, from https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/library\/white-papers\/future-of-rim-is-cross-funtional-integration.pdf."},{"key":"1283_CR115","unstructured":"European Medicines Agency. Introducing DADI: Digital Application Dataset Integration network project [Internet]. 2022. Retrieved July 21, 2025, from: https:\/\/esubmission.ema.europa.eu\/doc\/presentation-introducing-dadi-digital-application-dataset-integration-network-project-.pdf."},{"key":"1283_CR116","unstructured":"Artificial Intelligence Act. AI regulatory sandbox approaches: EU Member State overview. 2025. Retrieved July 29, 2025, from https:\/\/artificialintelligenceact.eu\/ai-regulatory-sandbox-approaches-eu-member-state-overview\/."},{"key":"1283_CR117","unstructured":"Gutierrez A, Phifer A, Westreich S, Maier E, Kosoy G, Moss M, Thanjavuru T, Serang O, Morgan M, Lababidi S, Johanson E. precision FDA: A sandbox for innovative collaborative omics advancement. US Food and Drug Administration; n.d. Retrieved July 24, 2025, from https:\/\/precision.fda.gov\/."},{"key":"1283_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.websem.2024.100847","volume":"85","author":"A Mero\u00f1o-Pe\u00f1uela","year":"2025","unstructured":"Mero\u00f1o-Pe\u00f1uela A, Simperl E, Kurteva A, Reklos I. KG.GOV: Knowledge graphs as the backbone of data governance in AI. J Web Semant. 2025;85:100847. https:\/\/doi.org\/10.1016\/j.websem.2024.100847.","journal-title":"J Web Semant"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01283-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:11:45Z","timestamp":1789755105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01283-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":118,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01283-2","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"156"}}